Japan's Otsuka Pharma has agreed to take control of US biotech Jnana Therapeutics in a deal that will give it rights to a clinical-stage candidate for the rare metabolic disorder phenylketonuria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback